| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 01/10/2012 | CA2521985C Follicle-stimulating hormone reduction agent |
| 01/10/2012 | CA2507184C 1, 2, 3- triazole amide derivatives as cytokine inhibitors |
| 01/10/2012 | CA2486183C Protein kinase inhibitors |
| 01/10/2012 | CA2479666C (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione: methods of using and compositions thereof |
| 01/10/2012 | CA2464334C Curcuminoid compositions exhibiting synergistic inhibition of the expression and/or activity of cyclooxygenase-2 |
| 01/10/2012 | CA2455559C Methods to mobilize progenitor/stem cells |
| 01/10/2012 | CA2436665C Nucleic acid derivatives |
| 01/10/2012 | CA2404488C Human aminoacyl-trna synthetase polypeptides useful for the regulation of angiogenesis |
| 01/10/2012 | CA2382105C Substituted pyridino pentaazamacrocyle complexes having superoxide dismutase activity |
| 01/10/2012 | CA2348167C Pharmaceutical administration form for peptides, process for its preparation, and use |
| 01/10/2012 | CA2334483C Compositions of restricted cells capable of rapid growth which produce proliferation suppressive materials, and uses thereof |
| 01/10/2012 | CA2267650C Non-naturally occurring lipoprotein particle |
| 01/08/2012 | CA2745289A1 Films for delivery of a therapeutic agent |
| 01/05/2012 | WO2012003472A1 Anti-notch1 antibodies |
| 01/05/2012 | WO2012003466A1 Single-walled carbon nanotube/sirna complexes and methods related thereto |
| 01/05/2012 | WO2012003421A2 Combinational compositions and methods for treatment of cancer |
| 01/05/2012 | WO2012003338A1 COMBINATION OF A cMET INHIBITOR AND AN ANTIBODY TO HGF AND/OR cMET |
| 01/05/2012 | WO2012003287A2 Compositions and methods for detecting and quantifying circulating tumor cells ctcs |
| 01/05/2012 | WO2012003283A1 Heterocyclic compounds and their use as inhibitors of pi3k activity |
| 01/05/2012 | WO2012003271A1 Heterocyclic compounds and their use as inhibitors of pi3k activity |
| 01/05/2012 | WO2012003264A1 Nitrogen containing heterocyclic compounds as pik3 -delta inhibitors |
| 01/05/2012 | WO2012003262A1 Heterocyclic compounds and their use as inhibitors of pi3k activity |
| 01/05/2012 | WO2012003189A1 Compositions and methods for modulating the wnt signaling pathway |
| 01/05/2012 | WO2012002760A2 Method for treating and diagnosing cancer by using cell-derived microvesicles |
| 01/05/2012 | WO2012002582A1 Partial region polypeptide of reic/dkk-3 protein |
| 01/05/2012 | WO2012002568A1 Azaindole derivative |
| 01/05/2012 | WO2012002527A1 HETEROCYCLIC COMPOUND, AND p27 KIP1 DEGRADATION INHIBITOR |
| 01/05/2012 | WO2012002502A1 Dihydropyrimidinone derivative and pharmaceutical use thereof |
| 01/05/2012 | WO2012001418A1 Multi-metallic complexes |
| 01/05/2012 | WO2012001308A1 Method for synthesizing ergoline alkaloids from indolic bicyclic compounds by double cyclization, resulting materials, and intermediate materials |
| 01/05/2012 | WO2012001065A2 Method for preventing or treating skin tumor |
| 01/05/2012 | WO2012001064A2 Method for preventing or treating skin tumor |
| 01/05/2012 | WO2012001020A1 Novel tetrahydroquinoline derivatives |
| 01/05/2012 | WO2012000994A1 Llt-1 antibodies with new functional properties |
| 01/05/2012 | WO2012000970A1 Triazolopyridines as tyk2 inhibitors |
| 01/05/2012 | WO2012000906A1 Blockade of ccl18 signaling via ccr6 as a therapeutic option in fibrotic diseases and cancer |
| 01/05/2012 | WO2012000632A1 Pyrazolo-quinolines |
| 01/05/2012 | WO2012000595A1 2,4- diaryl - substituted [1,8] naphthyridines as kinase inhibitors for use against cancer |
| 01/05/2012 | WO2012000458A1 Telomerase activity inhibiting peptide and manufacturing method and application thereof |
| 01/05/2012 | WO2012000443A1 Recombinant tumor vaccine and method of producing such vaccine |
| 01/05/2012 | WO2012000421A1 Uses of gossypol derivatives in manufacture of antitumor medicaments |
| 01/05/2012 | WO2012000409A1 Peptides with activity of inhibiting angiogenesis and uses thereof |
| 01/05/2012 | WO2012000356A1 Quinazoline compounds |
| 01/05/2012 | WO2012000306A1 Phenyl nitrone compounds containing stilbene segment and use thereof |
| 01/05/2012 | WO2012000304A1 Heterocyclic alkynyl benzene compounds and medical compositions and uses thereof |
| 01/05/2012 | WO2012000253A1 Composition for injection comprising docetaxel and preparation method thereof |
| 01/05/2012 | WO2012000188A1 Recombinant tumor vaccine and method of producing such |
| 01/05/2012 | WO2012000182A1 Quinazoline compounds |
| 01/05/2012 | WO2012000118A1 Short and d-amino acid-containing polypeptides for therapeutic conjugates and uses thereof |
| 01/05/2012 | WO2012000103A1 Methods of targeting pten mutant diseases and compositions therefor |
| 01/05/2012 | WO2011140634A3 The n-domain of carcinoembryonic antigen and compositions, methods and uses thereof |
| 01/05/2012 | WO2011140595A3 Immunostimulatory and vaccine compositions |
| 01/05/2012 | WO2011126853A9 Prevention or delay of onset of oral mucositis |
| 01/05/2012 | WO2011118929A3 Novel crystal forms of epirubicin hydrochloride |
| 01/05/2012 | WO2011116344A9 Targeting cancer stem cells |
| 01/05/2012 | WO2011115998A3 Modulators of hec1 activity and methods therefor |
| 01/05/2012 | WO2011115819A3 Small molecule inhibitors of muc1 and methods of identifying the same |
| 01/05/2012 | WO2011112071A3 Synergistic effect of tocotrienols and curcumin |
| 01/05/2012 | WO2011109365A3 Concentrated protein formulations and uses thereof |
| 01/05/2012 | WO2011107870A3 Compounds and compositions and their use in the treatment of diseases related to copper retention |
| 01/05/2012 | WO2011106248A3 Trimethoxyphenyl inhibitors of tyrosine kinase |
| 01/05/2012 | WO2011103345A3 Methods and compositions for influencing tumors using microrna-185 as a tumor suppressor |
| 01/05/2012 | WO2011103175A3 Oxysterols that activate liver x receptor signaling and inhibit hedgehog signaling |
| 01/05/2012 | WO2011103007A3 10'-fluorinated vinca alkaloids provide enhanced biological activity against mdr cancer cells |
| 01/05/2012 | WO2011099764A3 Novel pyrimidine derivative for inhibiting the growth of cancer cells |
| 01/05/2012 | WO2011093684A3 THIENO[3,2-d]PYRIMIDINE DERIVATIVES HAVING INHIBITORY ACTIVITY ON PROTEIN KINASES |
| 01/05/2012 | WO2011091154A3 Use of human erythrocytes for prevention and treatment of cancer dissemination and growth |
| 01/05/2012 | WO2010139180A8 Naphthalene carboxamide derivatives as inhibitors of protein kinase and histone deacetylase, preparation methods and uses thereof |
| 01/05/2012 | WO2002092832A9 Human and non-human primate homologues of nkd protein, nucleic acid sequences encoding, and uses thereof |
| 01/05/2012 | US20120005767 Antibodies to insulin-like growth factor i receptor |
| 01/05/2012 | US20120004315 Selective Estrogen Receptor Modulator |
| 01/05/2012 | US20120004311 Optically pure apogossypol derivative as pan-active inhibitor of anti-apoptotic b-cell lymphoma/leukemia-2 (bcl-2) |
| 01/05/2012 | US20120004310 Non-peptide bdnf neurotrophin mimetics |
| 01/05/2012 | US20120004296 Chroman derivatives, medicaments and use in therapy |
| 01/05/2012 | US20120004294 Antitumor combination combining ave8062 and docetaxel |
| 01/05/2012 | US20120004289 Annexin a11 and associated genes as biomarkers for cancer |
| 01/05/2012 | US20120004288 Compounds for the modulation of beta-catenin expression |
| 01/05/2012 | US20120004285 Erbb-3 (her3)-selective combination therapy |
| 01/05/2012 | US20120004284 Pdk inhibitor compounds and methods of use thereof |
| 01/05/2012 | US20120004278 Linc rnas in cancer diagnosis and treatment |
| 01/05/2012 | US20120004275 Sceletium extract and uses thereof |
| 01/05/2012 | US20120004270 Selective Androgen Receptor Modulators |
| 01/05/2012 | US20120004263 Compounds for the treatment of pathologies associated with aging and degenerative disorders |
| 01/05/2012 | US20120004262 Phenylcyclopropylamine derivatives and their medical use |
| 01/05/2012 | US20120004261 Mif modulators |
| 01/05/2012 | US20120004260 Inhibition of fatty acid synthesis by iodo-nitrobenzamide compounds and methods of treatment thereof |
| 01/05/2012 | US20120004253 Novel Fused Pyrrolocarbazoles |
| 01/05/2012 | US20120004249 The polymorph forms of 4-anilinoquinazoline derivatives, the preparation methods and uses thereof |
| 01/05/2012 | US20120004246 Purinyl derivatives and their use as potassium channel modulators |
| 01/05/2012 | US20120004240 Inhibitors of akt activity |
| 01/05/2012 | US20120004235 Methods to treat cancer |
| 01/05/2012 | US20120004233 Tricyclic compounds as antagonists of prostaglandin d2 receptors |
| 01/05/2012 | US20120004228 Bis Aromatic Compounds for Use as LTC4 Synthase Inhibitors |
| 01/05/2012 | US20120004225 Bumetanide, furosemide, piretanide, azosemide, and torsemide analogs, compositions and methods of use |
| 01/05/2012 | US20120004224 Triheterocyclic Compounds and Compositions Thereof |
| 01/05/2012 | US20120004218 Novel tetrahydro-quinoline derivatives |
| 01/05/2012 | US20120004216 Modulators of atp-binding cassette transporters |
| 01/05/2012 | US20120004211 1,2,4-triazole derivatives as sigma receptor inhibitors |
| 01/05/2012 | US20120004210 Substituted quinazoline compounds |
| 01/05/2012 | US20120004207 Therapeutic uses of derivatives of piperidinyl-and piperidinyl-alkyl carbamates |